Skip to main content
. 2021 Apr 13;21:193. doi: 10.1186/s12903-021-01553-9

Table 4.

Spearman’s correlation coefficients (rs) between periodontal parameters, salivary cytokines and selected factors analyzed in the PCOS group (n = 31) and the control group (n = 28)

N GI BOP% PD IL-1β (pg/ml) IL-6 (pg/ml) TNF-α (pg/ml)
rs p rs P rs p rs p rs p rs p
PI 31 0.61 0.0003* 0.60 0.0004* 0.17 0.3512 − 0.07 0.6947 0.07 0.7259 0.07 0.7153
28 0.66 0.0002* 0.79 0.0000* 0.26 0.1733 − 0.35 0.0665 0.07 0.7277 − 0,10 0.5970
BMI 31 0.14 0.4101 0.26 0.1568 0.02 0.9029 − 0.17 0.3571 0.07 0.6964 0.18 0.3452
28 0.36 0.0604 0.40 0.0368* 0.37 0.0497* − 0.05 0.8151 − 0.17 0.3761 0.07 0.7333
Estradiol (pg/ml) 31 − 0.04 0.8202 0.05 0.7719 0.21 0.2492 − 0.24 0.1903 0.07 0.6980 0.05 0.7894
TT (ng/dl) 31 − 0.34 0.0622 − 0.27 0.1422 − 0.22 0.2417 0.08 0.6683 0.37 0.0400* 0.20 0.2891
FAI 31 − 0.20 0.2783 − 0.11 0.5495 − 0.18 0.3276 0.04 0.8403 0.32 0.0836 0.36 0.0491*
SHBG (nmol/l) 31 − 0.02 0.9164 − 0.15 0.4241 − 0.03 0.8560 − 0.02 0.9117 − 0.15 0.4308 − 0.15 0.4193
DHEA-S (µmol/l) 31 − 0.05 0.7884 − 0.15 0.4165 − 0.17 0.3561 0.33 0.0675 0.06 0.7482 0.26 0.1510
Cortisol (morning sample) (nmol/l) 31 0.14 0.4382 0.18 0.3333 0.08 0.6837 0.12 0.5308 0.30 0.1050 − 0.08 0.6852
Cortisol/DHEA-S 31 0.11 0.5609 0.30 0.0999 0.22 0.2265 − 0.09 0.6303 0.18 0.3397 − 0.18 0.3412
Fasting glucose (mg/dl) 31 − 0.04 0.8219 − 0.13 0.4844 − 0.27 0.1463 0.07 0.6979 0.05 0.7852 0.15 0.4104
Fasting insulin (mU/ml) 31 0.23 0.2044 0.36 0.0469* 0.21 0.2669 0.08 0.6780 0.24 0.2022 0.01 0.9716
HOMA-IR 31 0.28 0.1301 0.48 0.0068* 0.24 0.1866 0.11 0.5535 0.14 0.4456 0.04 0.8202
TC (mg/dl) 31 − 0.31 0.0869 − 0.06 0.7325 − 0.21 0.2683 0.09 0.6450 0.25 0.1815 0.06 0.7686
LDL-C (mg/dl) 31 − 0.34 0.0578 − 0.10 0.5803 − 0.26 0.1580 − 0.04 0.8361 0.29 0.1085 0.05 0.7960
HDL-C (mg/dl) 31 − 0.02 0.9027 − 0.05 0.7925 0.18 0.3306 0.29 0.1200 − 0.20 0.2831 − 0.14 0.4533
TG (mg/dl) 31 − 0.03 0.8745 0.16 0.3967 − 0.15 0.4183 0.27 0.1436 0.31 0.0857 0.14 0.4475
Salivary testosterone (pg/ml) 31 − 0.44 0.0138* − 0.37 0.0424* − 0.06 0.7338 0.00 0.9888 0.33 0.0740 0.07 0.7019
28 0.11 0.5725 − 0.05 0.8197 − 0.16 0.4145 0.01 0.9526 0.01 0.9438 0.41 0.0312*
TNF-α (pg/ml) 31 − 0.26 0.1664 − 0.13 0.4909 − 0.20 0.2910 − 0.15 0.4318 0.54 0.0018* N.A N.A
28 0.35 0.0668 0.10 0.6007 0.00 1.0000 0.19 0.3240 0.12 0.5471 N.A N.A
IL-6 (pg/ml) 31 − 0.24 0.1976 − 0.07 0.7172 − 0.10 0.5991 0.05 0.3935 N.A N.A
28 0.01 0.9801 − 0.06 0.7510 − 0.20 0.3046 0.25 0.2006 N.A N.A
IL-1β (pg/ml) 31 0.06 0.7342 0.08 0.6759 0.06 0.7680 N.A N.A
28 − 0.14 0.4634 − 0.26 0.2551 0.01 0.9643 N.A N.A

TT, total testosterone; FAI, free androgen index; SHGB, sex hormone-binding globulin; DHEA-S, dehydroepiandrosterone sulfate; HOMA-IR, Homeostatic Model Assessment of Insulin Resistance; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides; TNF-α, tumor necrosis factor α; IL-6, interleukin 6; IL-1β, interleukin 1β; N.A., not applicable

*Statistically significant correlations